Senegal Malaria Financial Landscape

Transcription

1 Senegal Malaria Financial Landscape PATH MACEPA DECEMBER 2015 MALARIA FUNDING IN SENEGAL AT A GLANCE The estimated cost to fully fund Senegal s Strategic Framework is 124,086,654, or approximately $165 million. The estimated cost to fully fund the Strategic Framework for the years is approximately $119.5 million. The US President s Malaria Initiative (PMI) estimates that there will be a gap of approximately 1.6 million long-lasting insecticidal nets (LLINs) in 2016, when a planned nationwide LLIN distribution campaign will occur, and a gap of approximately one million LLINs in In recent years (the period ), PMI provided approximately 60 percent of Senegal s malaria funding, spending over 101 million on malaria programs and activities. During this same period, the Global Fund provided approximately 30 percent of malaria funding, spending more than 50 million from BACKGROUND The funding requirements for Senegal s National Malaria Control Program (NMCP) are based on the goals and objectives included in its National Strategic Framework. 1 Senegal s Strategic Framework General Objectives 2 (1) To reduce malaria-related morbidity in order to achieve the epidemiological pre-elimination threshold by (2) To reduce malaria-related mortality by 75 percent by Strategic Framework Specific Objectives (1) To protect at least 80 percent of pregnant women through intermittent preventive treatment (IPT) using sulfadoxinepyrimethamine (SP, 3 doses). (2) To protect at least 80 percent of pregnant women through long-lasting insecticidal nets (LLINs). (3) To provide seasonal malaria chemoprevention (SMC) to 98 percent of targeted children. (4) To get at least 80 percent of the population sleeping under LLINs. (5) To protect at least 90 percent of the population through indoor residual spraying (IRS) in targeted areas. (6) To treat at least 95 percent of productive breeding sites in targeted areas. (7) To diagnose 100 percent of suspected cases via rapid diagnostic tests (RDTs), microscopy and, where necessary, molecular biology in the pre-elimination areas. (8) To diagnose at least 95 percent of suspected cases by RDT or thick smear. (9) To treat 100 percent of confirmed cases of malaria according to national guidelines. (10) To provide pre-referral treatment to 100 percent of severe malaria cases among children under the age of 10. (11) To detect 100 percent of epidemics and emergency situations early on. (12) To control 100 percent of epidemics and emergency situations in the two weeks following their detection. Priority Areas The Strategic Framework identifies seven priority areas to support the achievement of the Strategic Framework objectives. 1. Case management: strategy development to ensure universal access to diagnostic testing (by RDT or microscopy) and treatment by artemisinin-based combination therapies (ACTs). 2. Prevention: working toward universal coverage of LLINs through mass campaigns and routine distribution. Routine distribution to be achieved through antenatal care (ANC), community based-organizations, schools, and the private sector. SP will be administered to pregnant women under direct observation (IPT). IRS will be implemented in selected areas to ensure a greater impact in terms of lowering transmission and thus lowering the number of cases. The larval management 1 Cadre Stratégique National De Lutte Contre Le Paludisme au Sénégal, Senegal Concept Note to Global Fund, , pgs SENEGAL MALARIA FINANCIAL LANDSCAPE DECEMBER 2015 PAGE 1

2 program will be rolled out in areas where this is possible. SMC will be implemented in parts of the country where the rainy season lasts 4 months, with 60 percent of malaria cases occurring during this period. This will be through the administration of SP and amodiaquine to children aged 3 months to 10 years. 3. Management and coordination: specific interventions to focus on strengthening the management unit and coordination mechanisms. 4. Information, education, and communication (IEC)/Behavior change communication (BCC): IEC/BCC and health promotion will be strengthened by focusing on evidence-based strategies. 5. Surveillance and response: weekly surveillance in areas of low transmission and monthly surveillance in the rest of the country. Investigation of cases will be conducted in the pre-elimination areas. Reactive monitoring resulting from the passive detection of cases will be vital. Specific surveillance of mobile populations (pastoralists/migrants) will be provided by establishing a system of home-based care (PECADOM) in the different communities. The DSDOMs will, in particular, notify the morbidity data gathered. 6. Supply and inventory management: improvements to avoid stock-outs through good planning and also good distribution of supplies. 7. Strengthened monitoring/evaluation and research: enabling better monitoring of progress and a consolidation of lessons learned. SENEGAL S MALARIA FINANCING REQUIREMENTS The Government of Senegal has estimated the cost of fully funding the Strategic Framework at 124,086,654, or $165,035, The average annual cost to implement Senegal s malaria program for is approximately 24.8 million, or $33 million. The Government of Senegal has estimated the cost of fully funding the Strategic Framework for the years at approximately $119.5 million. Senegal s Concept Note to the Global Fund for states that the 43,025,915 malaria funding request to the Global Fund would meet 50 percent of Senegal s Strategic Framework funding needs for this period. 4 Doubling the request yields a total malaria funding need of 86,051,830, or approximately $114,448,934, for Adding Senegal s projected domestic contribution of $5,076,396 for yields a total funding requirement of $119,525,330. SENEGAL S MALARIA FINANCING COMMITMENTS HISTORICAL Historically, PMI and the Global Fund have been major donor partners to Senegal. Other major partners include the World Health Organization (WHO), UNICEF, and the Islamic Development Bank (IDB), as shown in Table 1. Table 1. Malaria Financing for Senegal, by Partner, Year Domestic PMI/USAID Global Fund World Bank WHO UNICEF Islamic Development Bank 2009 $449,813 $18,700,000 $14,300,000 - $288, $155,764 $26,400,000 $2,507,790 - $97,987 - $8,000, $118,000 $24,500,000 $1,118,536 - $372,518 $617, $23,800,000 $20,700,000 - $30,117 $443, $213,986 $24,120,000 $3,660,000 $62,000 $12,490 $200, $24,800 $24,000,000 $21,674,466 - $12,491 $9,780-3 Senegal Concept Note to Global Fund, , p. 19. The Concept Note expresses the estimated total malaria funding requirement in euros. The conversion from euros to US dollars is based on the one-year average exchange rate for 2014 (an average of weekly exchange rates from January 1, 2014, to December 31, 2014) of 1.00 euro to 1.33 US dollars. 4 Senegal Concept Note to Global Fund, , p. 20. Senegal s projected domestic contributions for will be added to this total to obtain the total funding requirement for Senegal Concept Note to Global Fund, , p World Health Organization. World Malaria Report Annex 3, Funding for Malaria Control, World Health Organization. World Malaria Report Annex 3, Funding for Malaria Control, World Health Organization. World Malaria Report Annex 3, Funding for Malaria Control, US President s Malaria Initiative. FY 2016 Senegal Malaria Operational Plan for Senegal, p. 14. SENEGAL MALARIA FINANCIAL LANDSCAPE DECEMBER 2015 PAGE 2

3 Figure 1. Malaria Financing for Senegal, by Partner, Islamic Development Bank 4% Other 1% Govt. of Senegal 4% Global Fund 30% USAID/PMI 60% UNICEF 1% Malaria Financing for Senegal, by Partner, As shown in Figure 1, USAID/PMI accounted for approximately 60 percent of malaria funding during the period This represents spending of more than 101 million on malaria activities in Senegal. The Global Fund (which spent more than 50 million in ) provided approximately 30 percent of funding for malaria efforts during this period. The Government of Senegal contributed approximately 6.9 million in , or approximately 4 percent of total spending. MALARIA FINANCING COMMITMENTS Total estimated malaria funding commitments for in Senegal are approximately $118.9 million. Figures for commitments are based where possible on publicly available data concerning future spending (as for the Global Fund). Otherwise, projected spending is based on 2014 funding levels. Additional detail about the methodology for developing funding estimates is provided in footnote citations. Table 2 below is intended to provide only a general picture of the malaria financial landscape in Senegal for Funding figures may change as additional data about future spending become available. Table 2. Total Malaria Funding Commitments, Partner Commitments Global Fund 9 $38,610,564 USAID/PMI (estimate based on 2014 spending level) 10 $63,794,913 Govt. of Senegal (estimate based on 2014 spending level) 11 $5,076,396 Islamic Development Bank 12 $10,000,000 Other sources (estimate based on 2014 spending level) 13 $1,448,559 Total estimated funding commitments $118,930,432 7 Senegal Concept Note to Global Fund, , p. 15. See Annex 1 for table from Concept Note showing annual funding commitments by partner in euros. 8 Senegal Concept Note to Global Fund, , p The Global Fund has approved two malaria grants for the period IntraHealth is the primary recipient of a $15,011,991 grant, while the National Malaria Control Program in Senegal (the Programme National de Lutte contre le Paludisme, or PNLP) is the primary recipient of a $23,598,573 grant. $15,011,991 + $23,598,573 = $38,610,564. Global Fund website, Funding Decisions page In its Concept Note to the Global Fund, the Government of Senegal reports that PMI spent 15,988,700 in Senegal in Multiplied by 1.33, the average exchange rate for 2014, this spending level is equal to $21,264,971. $21,264,971 x 3 = $63,794, In its Concept Note to the Global Fund, the Government of Senegal reports spending 1,272,280 on malaria activities in Multiplied by 1.33, the average exchange rate for 2014, Senegal s 2014 malaria spending totals $1,692,132. $1,692,132 x 3 years = $5,076, PMI notes that the Islamic Development Bank is finalizing a $10 million loan to Senegal to be disbursed in US President s Malaria Initiative. FY 2016 Senegal Malaria Operational Plan, p In its Concept Note to the Global Fund, the Government of Senegal estimates that 2014 malaria funding from UNICEF, WHO, and PATH MACEPA totals 363,047 (UNICEF spending of 117,386 + WHO spending of 7,331 + PATH MACEPA spending of 238,330). Multiplied by 1.33, the average exchange rate for 2014, this spending level is equal to $482,853. $482,853 x 3 years = $1,448,559. SENEGAL MALARIA FINANCIAL LANDSCAPE DECEMBER 2015 PAGE 3

4 COMMODITY GAP ANALYSES PMI has developed gap analyses for key malaria commodities in its FY 2016 Senegal Malaria Operational Plan. The tables below summarize PMI gap analysis estimates. PMI estimates that there will be a gap of approximately 1.6 million LLINs in 2016, when a nationwide LLIN distribution campaign is planned to occur, and a gap of approximately one million LLINs in Table 3. PMI Long-Lasting Insecticidal Net (LLIN) Gap Analysis, Total population 14,318,196 14,704,787 15,101,817 Routine distribution requirements 1,687, ,064 2,181,477 Mass distribution requirements 0 8,000,000 0 Total LLIN requirement 1,687,162 8,712,064 2,181,477 Total LLINs available (all sources) 2,714,000 7,125,974 1,200,000 Estimated LLIN gap (surplus) (1,026,838) 1,586, ,477 Table 4. PMI Rapid Diagnostic Test (RDT) Gap Analysis, Total RDT requirement 1,929,110 2,186,485 2,478,198 Total RDTs available (all sources) 1,900,000 2,500,000 2,813,515 Estimated RDT gap (surplus) 29,110 (313,515) (335,317) Table 5. PMI Artemisinin-Based Combination Therapy (ACT) Gap Analysis, Total ACT requirement 706, , ,454 Total ACTs available (all sources) 600,000 1,300,000 1,431,008 Estimated ACT gap (surplus) 106,525 (631,008) (797,554) Table 6. PMI Sulfadoxine-Pyrimethamine (SP) Gap Analysis, Estimated pregnancies 501, , ,300 Total SP requirement (in treatments) 1,176,325 1,205,538 1,235,420 SP (to be procured by CMS) 1,176,325 1,205,538 1,235,420 Estimated SP gap US President s Malaria Initiative. FY 2016 Senegal Malaria Operational Plan, p US President s Malaria Initiative. FY 2016 Senegal Malaria Operational Plan, p US President s Malaria Initiative. FY 2016 Senegal Malaria Operational Plan, p US President s Malaria Initiative. FY 2016 Senegal Malaria Operational Plan, p. 33. SENEGAL MALARIA FINANCIAL LANDSCAPE DECEMBER 2015 PAGE 4

5 Annex 1. Malaria Financing for Senegal, by Partner, Govt. of Senegal 1,646,449 1,317, , ,867 1,251,867 1,272,280 USAID/PMI 13,329,502 13,209,194 16,585,264 24,123,938 18,168,690 15,988,700 UNICEF 470, , ,392 31,790 58, ,386 WHO 263,708 74, ,377 29,241 17,677 7,331 Global Fund 9,823,835 1,922, ,668 15,296,254 14,302,916 7,949,346 IDB 6,214, Japan ,263 France , PATH MACEPA , , , ,330 Total 31,747,922 16,993,452 19,013,878 40,494,974 33,976,175 25,573, Senegal Concept Note to Global Fund, , p. 15. SENEGAL MALARIA FINANCIAL LANDSCAPE DECEMBER 2015 PAGE 5